DHS Working Papers No. 110 | Zimbabwe Working Papers No. 11
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them. Here you can find informations to laws &policies, compliance action, ....
Doc. No.: INS/GDL/001-(Annexes)
ARC resource pack - Study material
Assessing and improving quality and human rights in mental health and social care facilites
DHS Working Papers No. 113
Psychiatry and Pediatrics
Chapter I.4